24/7 Market News Snapshot 05 September, 2024 – Co-Diagnostics, Inc. Common Stock (NASDAQ:CODX)

September 5, 2024

DENVER, Colo., 05 September, 2024 (247marketnews.com) – (NASDAQ:CODX) are discussed in this article.
Co-Diagnostics, Inc. (CODX) has recently experienced a notable surge in its stock price, opening at $1.26 and rising to $1.417, reflecting an increase of 13.36%. This growth follows a close of $1.250 in the previous trading session, signaling heightened investor interest in the company. With a current trading volume of approximately 517.79K, active participation in the market is evident. Traders are advised to keep an eye on support at $1.25 and anticipate resistance levels around $1.50. Continued volume growth could signal further bullish momentum, positioning CODX as a stock to monitor for potential volatility and price fluctuations in the forthcoming sessions.

In parallel, Co-Diagnostics has announced a pivotal advancement in its diagnostic efforts against mpox, previously known as monkeypox. The company asserted that its Co-Dx™ Logix Smart® Mpox (2-Gene) test demonstrates full reactivity against various mpox strains, including the clade Ib variant, following an in silico analysis. This proactive development addresses urgent concerns raised by both the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization, which have classified mpox as a Public Health Emergency of International Concern. With reported cases surpassing 22,800 and over 600 fatalities in recent months, clade Ib has become a significant concern.

Co-Diagnostics has designed and verified two Research Use Only (RUO) tests for mpox as part of its innovative Co-Primers® platform. Recent studies have confirmed that the 2-gene variant remains a superior detection tool, reinforcing the company’s commitment to advancing PCR testing solutions. “We are addressing the increasing demand for our test kits globally,” stated CEO Dwight Egan, highlighting the company’s mission to improve access to quality diagnostic tools for infectious diseases.

Related news for (CODX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.